Publications

BibTex format

@unpublished{Walsh:2018:10.1101/381467,
author = {Walsh, R and Mazzarotto, F and Whiffin, N and Buchan, R and Midwinter, W and Wilk, A and Li, N and Felkin, L and Ingold, N and Govind, R and Ahmad, M and Mazaika, E and Allouba, M and Zhang, X and Marvao, AD and Day, S and Ashley, E and Colan, S and Michels, M and Pereira, A and Jacoby, D and Ho, C and Thomson, K and Watkins, H and Barton, PJR and Olivotto, I and Cook, S and Ware, J},
doi = {10.1101/381467},
publisher = {bioRxiv},
title = {Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy},
url = {http://dx.doi.org/10.1101/381467},
year = {2018}
}

Download

RIS format (EndNote, RefMan)

TY  - UNPB
AB  - ABSTRACT Background International guidelines for variant interpretation in Mendelian disease set stringent criteria to report a variant as (likely) pathogenic, prioritising control of false positive rate over test sensitivity and diagnostic yield. Genetic testing is also more likely informative in individuals with well-characterised variants from extensively studied European-ancestry populations. Inherited cardiomyopathies are relatively common Mendelian diseases that allow empirical calibration and assessment of this framework. Results We compared rare variants in large hypertrophic cardiomyopathy (HCM) cohorts to reference populations to identify variant classes with high prior likelihoods of pathogenicity, as defined by etiological fraction (EF). Analysis of variant distribution identified regions in which variants are significantly enriched in cases and variant location was a better discriminator of pathogenicity than generic computational functional prediction algorithms. Non-truncating variant classes with an EF≥0.95, and therefore clinically actionable, were identified in 5 established HCM genes. Applying this approach leads to an estimated 14-20% increase in cases with actionable HCM variants. Conclusions When found in a patient confirmed to have disease, novel variants in some genes and regions are empirically shown to have a sufficiently high probability of pathogenicity to support a “likely pathogenic” classification, even without additional segregation or functional data. This could increase the yield of high confidence actionable variants, consistent with the framework and recommendations of current guidelines. The techniques outlined offer a consistent, unbiased and equitable approach to variant interpretation for Mendelian disease genetic testing. We propose adaptations to ACMG/AMP guidelines to incorporate such evidence in a quantitative and transparent manner.
AU  - Walsh,R
AU  - Mazzarotto,F
AU  - Whiffin,N
AU  - Buchan,R
AU  - Midwinter,W
AU  - Wilk,A
AU  - Li,N
AU  - Felkin,L
AU  - Ingold,N
AU  - Govind,R
AU  - Ahmad,M
AU  - Mazaika,E
AU  - Allouba,M
AU  - Zhang,X
AU  - Marvao,AD
AU  - Day,S
AU  - Ashley,E
AU  - Colan,S
AU  - Michels,M
AU  - Pereira,A
AU  - Jacoby,D
AU  - Ho,C
AU  - Thomson,K
AU  - Watkins,H
AU  - Barton,PJR
AU  - Olivotto,I
AU  - Cook,S
AU  - Ware,J
DO  - 10.1101/381467
PB  - bioRxiv
PY  - 2018///
TI  - Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy
UR  - http://dx.doi.org/10.1101/381467
UR  - https://www.biorxiv.org/content/10.1101/381467v1
UR  - http://hdl.handle.net/10044/1/82591
ER  -

Download

DrPaulBarton

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)